Abstract
Purpose
Portal vein embolization (PVE) before extended right hepatectomy leads to an increase of the future liver remnant (FLR) volume, but predictive factors for sufficient hypertrophy are still unclear. The purpose of this study was to investigate parameters influencing the growth of FLR.
Methods
Patients undergoing PVE prior hepatic resection were evaluated. PVE was done using polyvinyl alcohol particles only. Volumetric analysis was performed before embolization and before hepatectomy. Success of PVE was determined as percental growth of the future liver remnant.
Results
Seventy-seven patients were included, and three cohorts were formed according to the hypertrophy of FLR. FLR increased from 448.2 ± 187 to 475.5 ± 191 in the poor, from 315.3 ± 86 to 469.1 ± 142 in the moderate, and from 283.4 ± 68 to 400.4 ± 110 in the good hypertrophy group. More cases of recanalization of the portal vein were observed in patients with poor hypertrophy (p = 0.016). Small FLR before PVE predict higher growth of the FLR (p = 0.006). Duration between PVE and surgery differed significantly: 22 (poor) vs. 32 (good) days (p = 0.040).
Discussion
No recanalization, small initial FLR and longer time were assessed with better FLR hypertrophy. More sufficient PVE techniques and postponed hepatectomy might improve the outcome. Small initial FLR should not be a disclosure for curative hepatectomy.
Similar content being viewed by others
References
Neuhaus P, Thelen A (2008) Radical surgery for right-sided Klatskin tumor. HPB (Oxford) 10(3):171–173. doi:10.1080/13651820801992708
Arnold D, Rummeny EJ, Kirchner T, Ridwelski K, Oettle H, Hartmann JT, Moehler M, Holscher A, Lang H, Schlitt HJ, Neuhaus P (2009) Diagnosis and treatment of liver metastases from primary colorectal tumour]. Onkologie 32(Suppl 2):7–12
Lim KC, Chow PK, Allen JC, Siddiqui FJ, Chan ES, Tan SB (2012) Systematic review of outcomes of liver resection for early hepatocellular carcinoma within the Milan criteria. Br J Surg 99(12):1622–1629
Helling TS (2006) Liver failure following partial hepatectomy. HPB (Oxford) 8(3):165–174
van den Broek MA, Olde Damink SW, Dejong CH, Lang H, Malago M, Jalan R, Saner FH (2008) Liver failure after partial hepatic resection: definition, pathophysiology, risk factors and treatment. Liver Int 28(6):767–780
Garcea G, Maddern GJ (2009) Liver failure after major hepatic resection. J Hepatobiliary Pancreat Surg 16(2):145–155
Mullen JT, Ribero D, Reddy SK, Donadon M, Zorzi D, Gautam S, Abdalla EK, Curley SA, Capussotti L, Clary BM, Vauthey JN (2007) Hepatic insufficiency and mortality in 1,059 noncirrhotic patients undergoing major hepatectomy. J Am Coll Surg 204(5):854–862. doi:10.1016/j.jamcollsurg.2006.12.032, discussion 862–854
de Meijer VE, Kalish BT, Puder M, Ijzermans JN (2010) Systematic review and meta-analysis of steatosis as a risk factor in major hepatic resection. Br J Surg 97(9):1331–1339
McCall J, Koea J, Gunn K, Rodgers M, Jarvis J (2001) Liver resections in Auckland 1998–2001: mortality, morbidity and blood product use. N Z Med J 114(1144):516–519
Abulkhir A, Limongelli P, Healey AJ, Damrah O, Tait P, Jackson J, Habib N, Jiao LR (2008) Preoperative portal vein embolization for major liver resection: a meta-analysis. Ann Surg 247(1):49–57. doi:10.1097/SLA.0b013e31815f6e5b
Kinoshita H, Sakai K, Hirohashi K, Igawa S, Yamasaki O, Kubo S (1986) Preoperative portal vein embolization for hepatocellular carcinoma. World J Surg 10(5):803–808
de Graaf W, van Lienden KP, van den Esschert JW, Bennink RJ, van Gulik TM (2011) Increase in future remnant liver function after preoperative portal vein embolization. Br J Surg 98(6):825–834. doi:10.1002/bjs.7456
Nishiyama Y, Yamamoto Y, Hino I, Satoh K, Wakabayashi H, Ohkawa M (2003) 99mTc galactosyl human serum albumin liver dynamic SPET for pre-operative assessment of hepatectomy in relation to percutaneous transhepatic portal embolization. Nucl Med Commun 24(7):809–817. doi:10.1097/01.mnm.0000080247.50447.34
Hirai I, Kimura W, Fuse A, Suto K, Urayama M (2003) Evaluation of preoperative portal embolization for safe hepatectomy, with special reference to assessment of nonembolized lobe function with 99mTc-GSA SPECT scintigraphy. Surgery 133(5):495–506. doi:10.1067/msy.2003.138
Stockmann M, Lock JF, Riecke B, Heyne K, Martus P, Fricke M, Lehmann S, Niehues SM, Schwabe M, Lemke AJ, Neuhaus P (2009) Prediction of postoperative outcome after hepatectomy with a new bedside test for maximal liver function capacity. Ann Surg 250(1):119–125. doi:10.1097/SLA.0b013e3181ad85b5
Shirabe K, Shimada M, Gion T, Hasegawa H, Takenaka K, Utsunomiya T, Sugimachi K (1999) Postoperative liver failure after major hepatic resection for hepatocellular carcinoma in the modern era with special reference to remnant liver volume. J Am Coll Surg 188(3):304–309
Abdalla EK, Barnett CC, Doherty D, Curley SA, Vauthey JN (2002) Extended hepatectomy in patients with hepatobiliary malignancies with and without preoperative portal vein embolization. Arch Surg 137(6):675–680, discussion 680–671
Lee KC, Kinoshita H, Hirohashi K, Kubo S, Iwasa R (1993) Extension of surgical indications for hepatocellular carcinoma by portal vein embolization. World J Surg 17(1):109–115
Shindoh J, Tzeng CW, Aloia TA, Curley SA, Zimmitti G, Wei SH, Huang SY, Mahvash A, Gupta S, Wallace MJ, Vauthey JN (2013) Optimal future liver remnant in patients treated with extensive preoperative chemotherapy for colorectal liver metastases. Ann Surg Oncol 20(8):2493–2500
de Baere T, Teriitehau C, Deschamps F, Catherine L, Rao P, Hakime A, Auperin A, Goere D, Elias D, Hechelhammer L (2010) Predictive factors for hypertrophy of the future remnant liver after selective portal vein embolization. Ann Surg Oncol 17(8):2081–2089
Nanashima A, Sumida Y, Shibasaki S, Takeshita H, Hidaka S, Sawai T, Shindou H, Abo T, Yasutake T, Nagayasu T, Sakamoto I (2006) Parameters associated with changes in liver volume in patients undergoing portal vein embolization. J Surg Res 133(2):95–101
Lesurtel M, Graf R, Aleil B, Walther DJ, Tian Y, Jochum W, Gachet C, Bader M, Clavien PA (2006) Platelet-derived serotonin mediates liver regeneration. Science 312(5770):104–107
Dindo D, Demartines N, Clavien PA (2004) Classification of surgical complications: a new proposal with evaluation in a cohort of 6336 patients and results of a survey. Ann Surg 240(2):205–213
Stockmann M, Lock JF, Malinowski M, Niehues SM, Seehofer D, Neuhaus P (2010) The LiMAx test: a new liver function test for predicting postoperative outcome in liver surgery. HPB (Oxford) 12(2):139–146. doi:10.1111/j.1477-2574.2009.00151.x
Rahman SH, Evans J, Toogood GJ, Lodge PA, Prasad KR (2008) Prognostic utility of postoperative C-reactive protein for posthepatectomy liver failure. Arch Surg 143(3):247–253, discussion 253
Pepys MB, Hirschfield GM (2003) C-reactive protein: a critical update. J Clin Invest 111(12):1805–1812
Imamura H, Shimada R, Kubota M, Matsuyama Y, Nakayama A, Miyagawa S, Makuuchi M, Kawasaki S (1999) Preoperative portal vein embolization: an audit of 84 patients. Hepatology 29(4):1099–1105
Denys A, Lacombe C, Schneider F, Madoff DC, Doenz F, Qanadli SD, Halkic N, Sauvanet A, Vilgrain V, Schnyder P (2005) Portal vein embolization with N-butyl cyanoacrylate before partial hepatectomy in patients with hepatocellular carcinoma and underlying cirrhosis or advanced fibrosis. J Vasc Interv Radiol: JVIR 16(12):1667–1674. doi:10.1097/01.RVI.0000182183.28547.DC
Ribero D, Abdalla EK, Madoff DC, Donadon M, Loyer EM, Vauthey JN (2007) Portal vein embolization before major hepatectomy and its effects on regeneration, resectability and outcome. Br J Surg 94(11):1386–1394. doi:10.1002/bjs.5836
Hoekstra LT, van Lienden KP, Doets A, Busch OR, Gouma DJ, van Gulik TM (2012) Tumor progression after preoperative portal vein embolization. Ann Surg 256(5):812–817, discussion 817–818
Nagino M, Nimura Y, Kamiya J, Kondo S, Kanai M (1996) Selective percutaneous transhepatic embolization of the portal vein in preparation for extensive liver resection: the ipsilateral approach. Radiology 200(2):559–563
Hori T, Yagi S, Iida T, Taniguchi K, Yamagiwa K, Yamamoto C, Hasegawa T, Yamakado K, Kato T, Saito K, Wang L, Torii M, Hori Y, Takeda K, Maruyama K, Uemoto S (2007) Stability of cirrhotic systemic hemodynamics ensures sufficient splanchnic blood flow after living-donor liver transplantation in adult recipients with liver cirrhosis. World J Gastroenterol 13(44):5918–5925
Madoff DC, Abdalla EK, Gupta S, Wu TT, Morris JS, Denys A, Wallace MJ, Morello FA Jr, Ahrar K, Murthy R, Lunagomez S, Hicks ME, Vauthey JN (2005) Transhepatic ipsilateral right portal vein embolization extended to segment IV: improving hypertrophy and resection outcomes with spherical particles and coils. J Vasc Interv Radiol JVIR 16(2 Pt 1):215–225. doi:10.1097/01.RVI.0000147067.79223.85
Yoo H, Ko GY, Gwon DI, Kim JH, Yoon HK, Sung KB, Kim N, Lee J (2009) Preoperative portal vein embolization using an Amplatzer vascular plug. Eur Radiol 19(5):1054–1061. doi:10.1007/s00330-008-1240-2
Geisel D, Malinowski M, Powerski MJ, Wustefeld J, Heller V, Denecke T, Stockmann M, Gebauer B (2013) Improved hypertrophy of future remnant liver after portal vein embolization with plugs, coils and particles. Cardiovasc Intervent Radiol. doi:10.1007/s00270-013-0810-0
Kusaka K, Imamura H, Tomiya T, Makuuchi M (2004) Factors affecting liver regeneration after right portal vein embolization. Hepatogastroenterology 51(56):532–535
de Baere T, Denys A, Paradis V (2009) Comparison of four embolic materials for portal vein embolization: experimental study in pigs. Eur Radiol 19(6):1435–1442. doi:10.1007/s00330-008-1277-2
Owen RJ, Mercer JR, Al-Saif F, Molinari M, Ashforth RA, Rajotte RV, Conner-Spady B, Shapiro AM (2009) Portal vein embolization with radiolabeled polyvinyl alcohol particles in a swine model: hepatic distribution and implications for pancreatic islet cell transplantation. Cardiovasc Intervent Radiol 32(3):499–507. doi:10.1007/s00270-009-9544-4
Vollmar B, Menger MD (2009) The hepatic microcirculation: mechanistic contributions and therapeutic targets in liver injury and repair. Physiol Rev 89(4):1269–1339. doi:10.1152/physrev.00027.2008
Denys AL, Abehsera M, Leloutre B, Sauvanet A, Vilgrain V, O’Toole D, Belghiti J, Menu Y (2000) Intrahepatic hemodynamic changes following portal vein embolization: a prospective Doppler study. Eur Radiol 10(11):1703–1707
Acknowledgments
We greatly appreciate Sina Lehmann, Lina Demirel and Rea Roehl for their help in performing the study.
Conflicts of interest
Martin Stockmann is the inventor of the LiMAx test and has capital interest in Humedics, the company marketing the LiMAx test. Maximilian Jara disclosed receiving research grants in order of the d-LIVER European Commission Framework Programme (www.d-liver.eu). Remaining authors who have taken part in this study declared that they do not have anything to disclose regarding funding or conflict of interest with respect to this manuscript.
Authors’ contributions
MM and VS contributed to conception and design of the study, analysed and interpreted data, wrote the manuscript and finally approved the manuscript; JFL, AS, MJ, DS, TD and DG analysed and interpreted data, revised the manuscript and finally approved the manuscript; BG, PN and MS contributed to conception and design of the study, revised the manuscript and finally approved the manuscript.
Author information
Authors and Affiliations
Corresponding author
Additional information
Maciej Malinowski and Victoria Stary contributed equally to the manuscript.
Rights and permissions
About this article
Cite this article
Malinowski, M., Stary, V., Lock, J.F. et al. Factors influencing hypertrophy of the left lateral liver lobe after portal vein embolization. Langenbecks Arch Surg 400, 237–246 (2015). https://doi.org/10.1007/s00423-014-1266-7
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00423-014-1266-7